ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Kidney Diseases
Chronic Renal Insufficiency
Chronic Kidney Failure
IGA Glomerulonephritis
Renal Cell Carcinoma
Renal Insufficiency
Diabetic Nephropathies

Kidney Disease trials near Rochester, MN, USA:

A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (ANCHOR)

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that caus...

Enrolling
Autosomal Dominant Polycystic Kidney Disease
Drug: ABBV-CLS-628
Drug: Placebo

Phase 2

AbbVie
AbbVie

Rochester, Minnesota, United States and 65 other locations

and pharmacokinetics of AZD1613 following subcutaneous or intravenous administration in participants with autosomal dominant polycystic kidney...

Enrolling
Autosomal Dominant Polycystic Kidney Disease
Drug: Placebo - Part B
Drug: Placebo - Part A

Phase 1

AstraZeneca
AstraZeneca

Rochester, Minnesota, United States and 14 other locations

safety, tolerability, pharmacokinetics (PK) and Pharmacodynamics (PD) of DISC-0974 in adult participants with Non-Dialysis Dependent Chronic Kidney...

Active, not recruiting
Anemia of Chronic Kidney Disease
Chronic Kidney Diseases
Drug: DISC-0974
Drug: Placebo

Phase 1

Disc Medicine

Rochester, Minnesota, United States and 12 other locations

To evaluate the safety of tolvaptan in pediatric subjects with ARPKD

Enrolling
Autosomal Recessive Polycystic Kidney (ARPKD)
Drug: Tolvaptan Tablets
Drug: Tolvaptan Suspension

Phase 3

Otsuka
Otsuka

Rochester, Minnesota, United States and 22 other locations

This study is an open-label, multi-center study evaluating the clinical utility of Renasight in the diagnosis and management of kidney disease...

Active, not recruiting
Kidney Diseases
Diagnostic Test: Renasight
Natera
Natera

Rochester, Minnesota, United States and 30 other locations

The purpose of the study is to evaluate the effect of VX-407 on height-adjusted total kidney volume (htTKV), safety, tolerability, and pharm...

Enrolling
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Drug: VX-407

Phase 2

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Rochester, Minnesota, United States and 20 other locations

A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.

Enrolling
X-linked Hypophosphatemia
Drug: KK8123

Phase 1, Phase 2

Kyowa Kirin
Kyowa Kirin

Rochester, Minnesota, United States and 8 other locations

The proposed study is designed to provide patients previously enrolled in Phase 1 and 2 studies of DCR-PHXC and their siblings (\<18 years old) long-...

Active, not recruiting
Kidney Diseases
Genetic Disease
Drug: DCR-PHXC

Phase 3

Dicerna Pharmaceuticals

Rochester, Minnesota, United States and 22 other locations

PLD (ADPLD) or associated with autosomal dominant polycystic kidney disease (ADPKD).In the Treatment Period of the trial, participa...

Active, not recruiting
Polycystic Liver Disease
Drug: Placebo
Drug: CAM2029

Phase 2, Phase 3

Camarus

Rochester, Minnesota, United States and 10 other locations

or more. People can take part if they have cardiovascular or chronic kidney disease. People who have at least 2 health problems rel...

Active, not recruiting
Obesity
Drug: Placebo
Drug: survodutide

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Rochester, Minnesota, United States and 553 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems